Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Teva
Cipla
Julphar
Harvard Business School
Covington
Citi
McKinsey
Healthtrust
US Department of Justice

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019058

« Back to Dashboard
NDA 019058 describes TENORMIN, which is a drug marketed by Alvogen Malta and Astrazeneca and is included in two NDAs. It is available from two suppliers. Additional details are available on the TENORMIN profile page.

The generic ingredient in TENORMIN is atenolol. There are thirty-three drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the atenolol profile page.

Summary for NDA: 019058

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Sep 13, 1989TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Chubb
Teva
Deloitte
Express Scripts
Federal Trade Commission
Fuji
Queensland Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot